Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 11/20 | 0.60 |
| ▸ | CTSL | P07711 | 3/20 | 0.55 |
| ▸ | CTSS | P25774 | 3/20 | 0.55 |
| ▸ | CTSK | P43235 | 3/20 | 0.55 |
| ▸ | CTSH | P09668 | 1/20 | 0.55 |
| ▸ | DPP3 | Q9NY33 | 3/20 | 0.52 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.51 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.48 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.48 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31190180 | 0.90 | CXCR4 (0.60) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30808876 | 0.89 | CTSL (0.57) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30205377 | 0.89 | CXCR4 (0.61) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL31005883 | 0.89 | KISS1R (0.57) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30597309 | 0.88 | DPP3 (0.57) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL30307184 | 0.86 | CXCR4 (0.56) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL29978571 | 0.86 | CXCR4 (0.59) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL31290071 | 0.86 | CXCR4 (0.61) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL31593371 | 0.85 | CXCR4 (0.60) | CXCR4CTSLCTSSCTSKCTSH | |
| SCHEMBL31607206 | 0.85 | CXCR4 (0.61) | CXCR4CTSLCTSSCTSKCTSH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121851100-A | Ganoderma lucidum oligopeptide capable of inhibiting growth of tumor cells and preparation method and application thereof | 东阿辰康药业有限公司 | 2026-04-14 | — | — | CN | disclosed |